Is a complete CSE/DTC research report available?

Question

Accepted Answer

No complete published report is available for cse/DTC (CSE/DTC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap	36.4M
Net income (ttm)	-6M
EPS (ttm)	-CA$0.10
Shares out	75.8M
Volume	9,500
Beta	1.42

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 35M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA24463V1013
Last refreshed	2026-09-13
Market cap	CAD 36.4M
Price	CAD 0.48
Price currency	CAD
Sector	Healthcare
Sic	2836
Symbol	cse/DTC
Website	https://defencetherapeutics.com

Metric	Value
Earnings Yield	-16.62%
FCF yield	-12.5%
P/B ratio	6.72x

Metric	Value
Net Income	CAD -6M
Net Income Growth Years	1%
ROA	-40.06
Roa5y	-193.2
ROCE	-44.67
ROE	-232.8
ROIC	-58.04

Metric	Value
Cagr1y	-32.41%
Cagr3y	-44.44%
Cagr5y	-43.18%
EPS Growth Years	1
Revenue Growth Years	0x

CSE/DTC (CSE/DTC)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/DTC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/DTC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CSE/DTC

Frequently asked questions

Metric	Value
Assets	CAD 9.4M
Cash	CAD 3M
Current Assets	CAD 3.3M
Current Liabilities	CAD 973,684
Debt	CAD 1.6M
Debt Equity	CAD 0.29
Debt FCF	CAD -0.34
Equity	CAD 5.4M
Interest Coverage	-13.06
Liabilities	CAD 4M
Long Term Assets	CAD 6.2M
Long Term Liabilities	CAD 3.1M
Net Cash	CAD 1.4M
Net Cash By Market Cap	CAD 3.82
Net Cash Growth	102.11%
Net Debt Equity	CAD -0.26
Tangible Book Value	CAD 5.4M
Tangible Book Value Per Share	CAD 0.07
WACC	12.16

Metric	Value
Current ratio	3.37
Net Working Capital	CAD -648,137
Quick ratio	3.36
Working Capital	CAD 2.3M

Metric	Value
1Y total return	-32.39%
200-day SMA	0.57
3Y total return	-82.86%
50-day SMA	0.45
50-day SMA vs 200-day SMA	50under200
5Y total return	-94.07%
All Time High	8.15
All Time High Change	-94.11%
All Time High Date	2021-09-10
All Time Low	0.37
All Time Low Change	31.51%
All Time Low Date	2026-07-23
ATR	0.03
Beta	1.42
Beta1y	0.54
Beta2y	0.38
Ch YTD	-33.33
High	0.48
High52	0.93
High52 Date	2025-12-03
High52ch	-48.39%
Low	0.48
Low52	0.37
Low52 Date	2026-07-23
Low52ch	31.51%
Ma50ch	6.83%
Price vs 200-day SMA	-15.86%
RSI	49.1
RSI Monthly	38.09
RSI Weekly	45.64
Sharpe ratio	-0.09x
Sharpe Ratio3y	-0.2x
Sharpe Ratio5y	-0.13x
Sortino ratio	-0.06
Sortino Ratio3y	-0.24
Sortino Ratio5y	-0.13
Total Return	-34.05%
Tr YTD	-33.33
Tr1m	20%
Tr1w	-5.88%
Tr3m	-4%

Metric	Value
Float	67,946,153%
Net Borrowing	1,981,634
Shares Insiders	10.35%
Shares Out	75,788,153
Shares Qo Q	6.65%
Shares Yo Y	34.05%

Metric	Value
Adjusted FCF	CAD -4.9M
Adjusted OCF	-4,889,662
Average Volume	66,813.4x
Bv Per Share	0.07
CAPEX	CAD -15,054
Ch1m	20
Ch1w	-5.88
Ch1y	-32.39
Ch3m	-4
Ch3y	-82.86
Ch5y	-94.07
Ch6m	-20
Change	-2.04%
Change From Open	0
Close	0.49
Days Gap	-2.04
Depreciation Amortization	20,848
Dollar Volume	4,560
Earnings Date	2026-09-18
EBIT	CAD -3.8M
EBITDA	CAD -3.8M
EPS	CAD -0.1
F Score	2
FCF	CAD -4.5M
FCF EV Yield	-13x
FCF Per Share	CAD -0.06
Financing CF	5,436,759
Fiscal Year End	June
Founded	2,017
Investing CF	-30,052
Is Primary Listing	1
Last Earnings Date	2026-02-23
Last Report Date	2026-03-31
Ma150	0.52
Ma150ch	-7.16%
Ma20	0.5
Ma20ch	-4.82%
Net CF	873,322
Next Earnings Date	2026-09-18
Open	0.48
Ppne	167,773
Price Date	2026-09-11
Ptbv Ratio	6.72
Relative Volume	0.14x
Share Based Comp	356,278
Tr6m	-20%
Volume	9,500